Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates

作者
Katayun Bahrami,Juulia Järvinen,Tuomo Laitinen,Mika Reinisalo,Paavo Honkakoski,Antti Poso,Kristiina M. Huttunen,Jarkko Rautio
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:20 (1): 206-218 被引量:23
标识
DOI:10.1021/acs.molpharmaceut.2c00594
摘要

L-type amino acid transporter 1 (LAT1) transfers essential amino acids across cell membranes. Owing to its predominant expression in the blood-brain barrier and tumor cells, LAT1 has been exploited for drug delivery and targeting to the central nervous system (CNS) and various cancers. Although the interactions of amino acids and their mimicking compounds with LAT1 have been extensively investigated, the specific structural features for an optimal drug scaffold have not yet been determined. Here, we evaluated a series of LAT1-targeted drug-phenylalanine conjugates (ligands) by determining their uptake rates by in vitro studies and investigating their interaction with LAT1 via induced-fit docking. Combining the experimental and computational data, we concluded that although LAT1 can accommodate various types of structures, smaller compounds are preferred. As the ligand size increased, its flexibility became more crucial in determining the compound's transportability and interactions. Compounds with linear or planar structures exhibited reduced uptake; those with rigid lipophilic structures lacked interactions and likely utilized other transport mechanisms for cellular entry. Introducing polar groups between aromatic structures enhanced interactions. Interestingly, compounds with a carbamate bond in the aromatic ring's para-position displayed very good transport efficiencies for the larger compounds. Compared to the ester bond, the corresponding amide bond had superior hydrogen bond acceptor properties and increased interactions. A reverse amide bond was less favorable than a direct amide bond for interactions with LAT1. The present information can be applied broadly to design appropriate CNS or antineoplastic drug candidates with a prodrug strategy and to discover novel LAT1 inhibitors used either as direct or adjuvant cancer therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
踏实的老四完成签到,获得积分10
刚刚
隐形羽毛完成签到,获得积分10
刚刚
桐桐的应助被漫漫采纳,获得10
刚刚
1秒前
SZZ完成签到,获得积分10
1秒前
1秒前
喵喵喵发布了新的文献求助10
1秒前
打打的应助被今天看文献了吗采纳,获得10
1秒前
1秒前
野性的发卡完成签到,获得积分10
1秒前
我是谁的应助被Tongtong采纳,获得10
2秒前
英俊的铭的应助被炫彩小陈采纳,获得10
2秒前
2秒前
2秒前
明理的千筹发布了新的文献求助100
3秒前
3秒前
文思发布了新的文献求助10
3秒前
hhdr完成签到 ,获得积分10
3秒前
hua完成签到 ,获得积分10
3秒前
Akim的应助被王梦姣采纳,获得10
3秒前
dd发布了新的文献求助10
3秒前
情怀的应助被美好的千凝采纳,获得10
4秒前
丫丫完成签到,获得积分10
4秒前
年轻冰夏完成签到,获得积分10
4秒前
5秒前
端庄醉山发布了新的文献求助10
5秒前
凤族无双发布了新的文献求助10
5秒前
派大星完成签到,获得积分20
5秒前
Fossette完成签到,获得积分10
5秒前
madecaosb完成签到,获得积分10
5秒前
爆米花的应助被霸气的数据线采纳,获得10
5秒前
OoO完成签到,获得积分10
5秒前
年轻的梦岚完成签到,获得积分20
5秒前
6秒前
务实的姿发布了新的文献求助10
6秒前
1234567完成签到,获得积分20
6秒前
yang1993完成签到,获得积分10
6秒前
无极微光的应助被cjn采纳,获得20
6秒前
陈亦昊完成签到 ,获得积分10
6秒前
鱼鱼鱼发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346